INVESTIGADORES
VICO Juan Pablo
artículos
Título:
PK/PD Analysis by Nonlinear Mixed-Effects Modeling of a Marbofloxacin Dose Regimen for Treatment of Goat Mastitis Produced by Coagulase-Negative Staphylococci
Autor/es:
LORENZUTTI, AUGUSTO MATÍAS; VICO, JUAN PABLO; SERRANO-RODRÍGUEZ, JUAN MANUEL; HIMELFARB, MARTÍN ALEJANDRO; ANDRÉS-LARREA, MANUEL IGNACIO SAN; LUCAS-BURNEO, JOSÉ JULIO DE; LITTERIO, NICOLÁS JAVIER
Revista:
Animals
Editorial:
Multidisciplinary Digital Publishing Institute
Referencias:
Lugar: Basel; Año: 2021 vol. 11
ISSN:
2076-2615
Resumen:
Coagulase-negative staphylococci are main pathogens that produce goat mastitis. Marbofloxacinis a third-generation fluoroquinolone approved for treat mastitis in animals. The objectivesof this study were: (i) to determine the pharmacokinetics of marbofloxacin (10 mg/kg/24 h) in serum and milk administered intramuscularly for five days in goats with mastitis induced by coagulasenegative staphylococci; (ii) to characterize the concentration?effect relationship of marbofloxacin against coagulase-negative staphylococci in Mueller Hinton broth and goat milk; (iii) to determine AUC/MIC cutoff values of marbofloxacin, and (iv) to perform a PK/PD analysis to evaluate the efficacy of the dose regimen for the treatment of goat mastitis produced by coagulase-negative staphylococci. Marbofloxacin presented context-sensitive pharmacokinetics, influenced by the evolution of the disease, which decreased marbofloxacin disposition in serum and milk. Marbofloxacin showed a median (95%CI) fAUC/MIC values for MIC of 0.4 and 0.8 g/mL of 26.66 (22.26?36.64) and 32.28 (26.57?48.35) related with 􀀀2 log10CFU/mL reduction; and 32.26 (24.81?81.50) and 41.39 (29.38?128.01) for 􀀀3 log10CFU/mL reduction in Mueller Hinton broth. For milk, 􀀀2 log10CFU/mL reduction was achieved with 41.48 (35.29?58.73) and 51.91 (39.09?131.63), and 􀀀3 log10CFU/mL reduction with 51.04 (41.6?82.1) and 65.65 (46.68?210.16). The proposed dose regimen was adequate for the treatment of goat mastitis produced by coagulase-negative staphylococci, resulting in microbiological and clinical cure of all animals. The animal model used in this study provided important pharmacokinetic information about the effect of the infection on the pharmacokinetics of marbofloxacin. Pharmacodynamic modeling showed that fAUC/MIC cutoff values were higher in goat milk compared with Mueller Hinton broth.